• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

More than half of Americans have COVID antibodies from a prior infection, CDC data show

By
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Bloomberg
Bloomberg
Down Arrow Button Icon
April 26, 2022, 1:49 PM ET

Well over half the U.S. Population has been infected with the coronavirus at some point, according to a nationwide study of blood samples, the latest evidence of COVID-19’s far-reaching impact.

As of February, 57.7% of Americans had antibodies to SARS-CoV-2 in their blood, health officials said, up from 33.5% in December, when the Omicron wave began sweeping across the country. While the antibodies aren’t necessarily protective, they indicate a previous infection.

With increased access to at-home testing and many people experiencing mild or asymptomatic cases, official COVID case counts have become increasingly unreliable. The blood survey is the best evidence available of the disease’s reach: It suggests that since the Omicron wave began late last year, almost a quarter of the country was newly infected with the virus.

Rates were even higher among children and teens, with about 75% of those up to age 17 now showing signs of infection, an increase of about 30 percentage points since December, according to the estimate. The survey period ran through February, meaning the actual rates are by now higher.

The data come from a Centers for Disease Control and Prevention study with medical laboratories conducting monthly surveys of tens of thousands of blood samples. The blood tests pick up antibodies to the virus, but exclude those sparked by vaccines, allowing researchers to deduce infection rates across the country. The tests can detect signs of the virus up to two years after an infection and in very small levels, but don’t necessarily mean people are protected from getting sick again. 

“Having infection-induced antibodies does not necessarily mean you are protected against future infection,” Kristie Clarke, co-leader of the CDC team surveying the blood markers, said on a call with reporters. “CDC continues to encourage all Americans to stay up to date with their COVID vaccinations.”

A separate CDC look at both types of antibodies has found that more than 90% of Americans have either been vaccinated or previously infected. 

Data from people age 65 and older also hint at the effectiveness of vaccines. While they’re among most vulnerable to COVID-19, the group also has the lowest rate of prior infection, with 33.2% showing antibodies that mark a past exposure to the virus, according to the CDC survey. 

That’s likely because the group is the U.S.’s most vaccinated, with 90% of seniors fully immunized and more than two-thirds of those vaccinated having received a booster. In contrast, younger people in the U.S. Who showed far higher rates of previous infection are less likely to have received shots. 

Older adults may also be “more conservative in using preventive measures,” Clarke said, which could explain some of the difference in rates. 

Blood surveys, combined with vaccination records, are crucial for understanding where the country is in the two-year-old pandemic that has claimed the lives of almost 1 million Americans, disrupted daily lives and rattled the economy. Prior infection has been associated with protection from the virus, though sometimes at great cost to people’s health. 

While the U.S. Has relatively good local records of vaccination, it does not have similarly detailed information on prior infection, in part because not every case is confirmed by a test. The country’s fragmented public health and medical records systems also play a role. 

Sign up for the Coins2Day Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.
About the Author
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.